Eversept Partners LP Acquires 2,252,202 Shares of Avantor, Inc. $AVTR

Eversept Partners LP increased its holdings in Avantor, Inc. (NYSE:AVTR) by 243.6% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 3,176,644 shares of the company’s stock after buying an additional 2,252,202 shares during the period. Avantor accounts for 1.8% of Eversept Partners LP’s investment portfolio, making the stock its 15th biggest position. Eversept Partners LP’s holdings in Avantor were worth $36,404,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of AVTR. Royal Bank of Canada lifted its stake in Avantor by 104.3% in the 1st quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock worth $3,302,000 after purchasing an additional 104,022 shares in the last quarter. Empowered Funds LLC lifted its stake in Avantor by 40.3% in the 1st quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock worth $286,000 after purchasing an additional 5,075 shares in the last quarter. Cetera Investment Advisers lifted its stake in Avantor by 40.2% in the 2nd quarter. Cetera Investment Advisers now owns 40,289 shares of the company’s stock worth $542,000 after purchasing an additional 11,543 shares in the last quarter. Quantbot Technologies LP purchased a new stake in Avantor in the 2nd quarter worth approximately $232,000. Finally, Arrowstreet Capital Limited Partnership lifted its stake in Avantor by 214.9% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 124,076 shares of the company’s stock worth $1,670,000 after purchasing an additional 84,679 shares in the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Avantor Stock Performance

Avantor stock opened at $9.46 on Thursday. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.17 and a current ratio of 1.76. Avantor, Inc. has a fifty-two week low of $7.26 and a fifty-two week high of $15.93. The firm’s fifty day moving average price is $8.48 and its 200-day moving average price is $9.57. The stock has a market cap of $6.46 billion, a P/E ratio of -11.67, a price-to-earnings-growth ratio of 5.55 and a beta of 0.97.

Avantor (NYSE:AVTR) last released its earnings results on Wednesday, April 29th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.16 by $0.01. Avantor had a negative net margin of 8.42% and a positive return on equity of 9.95%. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.54 billion. During the same quarter last year, the firm earned $0.23 EPS. The firm’s quarterly revenue was up .0% compared to the same quarter last year. On average, equities research analysts expect that Avantor, Inc. will post 0.79 earnings per share for the current fiscal year.

Insider Buying and Selling at Avantor

In other Avantor news, Director Gregory T. Lucier bought 10,000 shares of Avantor stock in a transaction that occurred on Friday, May 8th. The shares were bought at an average price of $8.32 per share, with a total value of $83,200.00. Following the acquisition, the director owned 60,000 shares in the company, valued at approximately $499,200. This trade represents a 20.00% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Simon Dingemans bought 25,000 shares of Avantor stock in a transaction that occurred on Friday, May 1st. The shares were acquired at an average cost of $8.14 per share, for a total transaction of $203,500.00. Following the acquisition, the director owned 25,000 shares in the company, valued at $203,500. The trade was a ? increase in their position. The SEC filing for this purchase provides additional information. 0.28% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on AVTR. Zacks Research upgraded shares of Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, April 30th. Wolfe Research cut shares of Avantor to an “underperform” rating and set a $7.00 target price on the stock. in a research note on Monday, June 1st. Wall Street Zen cut shares of Avantor from a “buy” rating to a “hold” rating in a research note on Saturday, May 30th. Barclays lowered their target price on shares of Avantor from $8.50 to $7.00 and set an “underweight” rating on the stock in a research note on Tuesday, April 14th. Finally, Citigroup lowered their target price on shares of Avantor from $11.00 to $9.00 and set a “neutral” rating on the stock in a research note on Thursday, April 30th. Two analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Reduce” and a consensus target price of $10.57.

Avantor Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.